In addition, quantitative analyses of molecular signatures supported that TN-401 treatment reduced mRNA expression of heart failure markers (a significant Nppa reduction and a trending Nppb reduction), fibrosis, and tissue remodeling genes in the right ventricles (only human PKP2 transgene expression was quantified) (Fig. 5e). This evidence concerns the gene PKP2 and heart failure.